Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sitagliptin Effects on Endothelial Function in T2DM
NCT01859793Phase 4Completed
- Sponsor
- Medical College of Wisconsin
- Start
- Jun 2013
- Primary completion
- Jan 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in type 2 diabetes mellitus (T2DM) comparing Sitagliptin with Matching Placebo (2 arms). Primary endpoint: Brachial Artery Flow Mediated Dilation at 8 weeks. Started Jun 2013; status: completed.
02
Drugs
sitagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01859793.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01859793.